Objective: It remains unclear whether drug-resistant temporal lobe epilepsy (TLE) is associated with cumulative brain damage, with no expert consensus and no quantitative syntheses of the available evidence.
maintain adequate quality of life, 5 controversy remains as to whether the disease follows a progressive course.
Quantitative MRI lends imaging markers with biological validity and high test-retest reliability, representing an objective framework to test for disease progression. While some studies suggested atrophy related to high seizure frequency and longer epilepsy duration, others did not. To quantitatively synthesize the currently attained level of evidence for progressive atrophy in TLE, we undertook a systematic review and meta-analysis. In addition to integrating findings from hippocampal and whole brain analyses, we provide a systematic overview of methodologic heterogeneity and potential shortcomings of previous work, and outline the need for prospective multicohort study designs to achieve higher levels of evidence for disease progression.
METHODS Search strategy and selection criteria. We conducted a systematic review and meta-analysis in accordance with Preferred Reporting Items for Systematic Reviews and MetaAnalyses (PRISMA) guidelines. 7 We searched PubMed and Ovid MEDLINE databases on English literature, with no date limits set. We queried the following terms: "temporal lobe epilepsy" or "TLE" and ("MRI" or "magnetic resonance" or "volumetry" or "voxel-based" or "cortical thickness"). The searches were last updated on October 6, 2015. We also carried out manual searches on reference lists of all the included studies and of selected review articles, and a gray literature search through manual consultation of the proceedings of recent annual meetings (2014) (2015) of the American Epilepsy Society. Initial screening was performed by one rater (L.C.) for the entire list. Assessment of full-text articles and final study selection was conducted independently by 2 reviewers (L.C. and B.C.B.); disagreement was settled by consensus. Based on 1,000 records screened independently by both L.C. and B.C.B., near-perfect interrater agreement (k 5 0.99) was obtained.
To be selected for quantitative analysis, reports had to meet the following criteria: (1) observational study in human cohorts with drug-resistant TLE, (2) participants evaluated using quantitative MRI methods (i.e., volumetry, voxel-based morphometry, cortical thickness analysis), (3) analyses specifically addressing disease progression (i.e., correlation with epilepsy duration, correlation with seizure counts, longitudinal design) at a hippocampal or whole brain level. Articles were excluded if they involved animals or if they were case series with fewer than 5 individuals.
Data extraction and quality assessment. To quantitatively synthesize methodologic variability, study designs were categorized as cross-sectional or longitudinal. Within the cross-sectional category, we stratified studies that addressed associations between structural MRI measures and (1) epilepsy duration, (2) frequency/ counts of complex partial seizures, (3) frequency/counts of secondarily generalized seizures.
For the included studies, we extracted patient sample characteristics (number of participants, age range, epilepsy duration range), MRI field strength, quantitative MRI methodology, and method for age control (when performed). Each report was assigned to 2 non-mutually exclusive sections: (1) evaluation of cumulative hippocampal atrophy, for which meta-analytical statistical methods were implemented; and (2) assessment of whole brain cumulative atrophy, pertaining to all brain structures other than the hippocampus, for which we summarized evidence using narrative synthesis.
Pearson correlation coefficient r was extracted as unit of analysis for the subset of studies addressing hippocampal atrophy and its association with epilepsy duration and seizures. When the latter metric was not directly provided, conversions were conducted according to established methods. 8 Where both bivariate and partial correlations were reported within the same study, we used the latter. When separate or multiple metrics were reported (e.g., for distinct patient subgroups), weighted averages were generated to obtain a single study-specific measure. Due to considerable between-study variability in the reporting of results, correlations between MRI markers and partial or secondary generalized seizures were pooled and averaged into one single category of seizure estimates.
For data included in the narrative synthesis on whole brain progression, Pearson r, Spearman r, or the relevant values of t/z statistics were all equally accepted and extracted as units of analysis.
Quality of evidence was assessed according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) framework, 9 implementing the relevant adjustments suggested for prognostic research studies. 10 Data synthesis and analysis. The meta-analysis for progressive hippocampal atrophy was conducted using the Metafor toolbox 11 implemented in R (version 3.2.2; R-project.org), after unbiased estimates of correlation coefficients were obtained to account for its moderate negative bias. We opted for random effects models to account for potential between-study heterogeneity, and fitted meta-regression models to assess (1) effects of epilepsy duration on the hippocampus ipsilateral to the seizure focus, (2) effects of epilepsy duration on the contralateral hippocampus, (3) effects of seizure estimates on the ipsilateral hippocampus, and (4) effects of seizure estimates on the contralateral hippocampus. We also assessed equivalent mixedeffect models with volumetric technique (automated vs manual) as a categorical moderator.
Inspection of funnel plots and Galbraith plots, together with regression tests relating effect size to sample size, addressed small sample and publication bias. The I 2 metric was implemented to quantify residual heterogeneity.
We excluded duplicate publications and performed 3 sensitivity analyses, which included only one type of study at a time from a given research group, i.e., the first study, the last study, or the one with the largest sample size.
For the narrative synthesis on whole brain progression, we summarized evidence from previous studies employing voxelbased morphometry, volumetry, cortical thickness mapping, and surface shape analyses. We counted reports of progressive structural changes in patients within the following regional categories, similar to a previous review on whole brain voxel-based morphometric studies 12 : (1) mesiotemporal, (2) extramesiotemporal, (3) extratemporal, (4) subcortical. Progression was considered as detected in the presence of (1) significant correlations between MRI markers and seizure estimates or epilepsy duration and (2) pertaining to either ipsilateral or contralateral regions of interest. For volumetric studies already included in the metaanalysis on hippocampal findings, the focus was limited to structures other than the hippocampus.
Standard protocol approvals, registrations, and patient consents. Individual studies were approved by local ethics committees. No additional ethical approval was required for this systematic review and meta-analysis.
RESULTS
Study selection. For a flow diagram detailing PRISMA-guided study selection, see figure 1.
Screening. We identified 2,667 citations through PubMed, 295 additional records through Ovid, and 14 further records by searching reference lists. The title and abstract of the resulting 2,976 citations were screened for eligibility; of these, 2,728 records were excluded based on the following criteria: (1) manuscript type (reviews/opinion papers, non-TLE studies, case reports; n 5 872); (2) TLE studies not employing imaging (n 5 979); (3) TLE imaging studies not employing MRI (n 5 327); (4) MRI studies on TLE not assessing gray matter (n 5 333); (5) MRI studies on TLE not assessing progression (n 5 217).
Eligibility. Full-text review of the remaining 248 reports resulted in exclusion of 206 articles based on the following criteria: (1) no assessment of progression (n 5 138); (2) sample characteristics (no drug-resistant TLE, pediatric cohort, small sample size; n 5 28); (3) no assessment of gray matter morphometry (n 5 15); (4) insufficient data (n 5 25). The remaining 42 articles were included in the systematic review.
Systematic review. The systematic review included 42 studies (table e-1 at Neurology.org) conducted between 1997 and 2015. Articles were categorized into those assessing (1) progressive hippocampal atrophy based on quantitative MRI volumetry (n 5 19) and (2) whole brain progression (n 5 28, 5 also included in no. 1). Two studies 16, 25 evaluated the same cohort, for which results are reported once only. One study 41 reported separate cross-sectional and longitudinal analyses, and each report is counted individually.
Sample and study characteristics. The 42 analyses included a total of 2,188 patients with TLE (961 male, age 9-74 years, epilepsy duration 0-58 years). Thirty-two studies were based on 1.5T MRI, 2 on 2T, 32 An inherent limitation of all analyses addressing cumulative atrophy is the confounding effect of age (i.e., chronological age), which is highly correlated with disease duration. 41 This caveat appears particularly relevant for cross-sectional studies. In 18 of the latter (47.4%), 14, 16, [20] [21] [22] 24, 30, [33] [34] [35] [36] [37] [38] 40, 42, [50] [51] [52] no statistical approaches were implemented to correct for the effects of age. Although the remaining studies addressed aging, no consistent method was chosen: 3 reported no significant effects of age on morphometric measures in controls, 15, 32, 48 3 found no effect of age or no effect of age at epilepsy onset in patients, 19 ,29,53 2 corrected for age at onset, 18,28 5 corrected for age in patients, 17, 26, 47, 49, 54 4 utilized MRI measures adjusted for age 13, 31, 39, 46 (based on regression models derived from controls), 1 calculated epilepsy duration/age ratios, 23 2 statistically compared chronological age effects between patients and controls. 41, 45 Among the longitudinal studies, 3 were singlecohort studies of patients without controls (interscan interval ranging from 2.3 to 3.4 years 27, 41, 44 ). One study followed a multicohort design with a median interscan interval of 3.3 years, but without statistically comparing patients to controls. 43 Three analyses reported parametric modulations of change trajectories by measures of seizure frequency. 27, 43, 44 Systematic review and meta-analysis on progressive hippocampal atrophy. Progression of hippocampal atrophy was assessed in 19 studies involving 979 patients (study sample size mean 6 SD 51.5 6 32.7, range 12-153) (figure 2). Of these, 1 was longitudinal 27 and 18 were cross-sectional; of the latter, 8 assessed correlation with epilepsy duration, 3 with seizure estimates, and 7 with both. Hippocampal measures were frequently based on manual volumetry (n 5 15, with 5 explicitly mentioning blinded assessment 14, 16, 17, 24, 50 ). Four more recent analyses 31, 34, 40, 46 used automated approaches. Mixed-effect models revealed a significant moderator effect of volumetric technique (automated vs manual) for results reported on the ipsilateral hippocampus, both for correlational analyses with epilepsy duration (p 5 0.02; amount of variance accounted for: 46.55%, I
2 of mixed-effect model: 49.56%) and those with seizure estimates (p 5 0.03; variance 5 59.16%, I 2 5 39.30%). In both cases, studies that employed automated segmentations detected stronger correlations than those based on manual segmentations. While a moderation by volumetric technique was also seen for correlations between epilepsy duration and volume of the contralateral hippocampus, Figure 2 Meta-analysis on progressive hippocampal atrophy Pooled effect size for the ipsilateral (A) and contralateral (B) hippocampus for studies that assessed the effects of epilepsy duration (left) and of seizure estimates (right) on hippocampal volumes. For each subsection, funnel plots (left side, relating study-wise effect size to standard error) and graphs for regression tests (right side, relating effect size to sample size) are provided. CI 5 confidence interval.
this was in the opposite direction, i.e., studies based on manual volumetry reported larger effects than those based on automated techniques (p 5 0.049; variance 5 23.77%, I 2 5 77.64%). Conversely, volumetric technique did not moderate the relation between seizure estimates and contralateral hippocampal volumes (p 5 0.56; I 2 5 85.45%). Funnel plots for random and mixed-effects models (figures 2 and 3, respectively) appeared symmetric, Galbraith plots did not indicate the presence of outliers in effect size (figure 3), and there was no evidence of publication bias. Regression tests showed a small yet marginally significant effect of sample size on the effect size of the correlation between epilepsy duration and ipsilateral hippocampal volume (p 5 0.03).
The 3 sensitivity analyses yielded results that were similar to the overall analyses. In the analysis of the first published study per author group for the ipsilateral hippocampus, the pooled effects sizes for epilepsy duration were r 5 20. 2 5 67.11% based on 9 studies), though evaluating the effect of seizure estimates was impeded by the small number of studies (n 5 2). Conversely, it was not possible to separately analyze patients with hippocampal pathology and those with normal-appearing hippocampi, as studies generally included mixed samples comprising both subgroups with varying MRI diagnostic criteria.
Implementation of GRADE recommendations adapted for prognostic research yielded an overall score of 2.5 for evidence pertaining to ipsilateral hippocampal atrophy, and of ,1 for contralateral atrophy, reflecting low to moderate and very low confidence in effect estimates, respectively (tables e-3 and e-4).
Narrative synthesis on whole brain progression. As with the assessment of the hippocampus, most analyses (25/28) followed a cross-sectional design (10 in relation to epilepsy duration and 15 including both Figure 3 Galbraith (radial) plots for random effects models and funnel plots for mixed-effect models (A) Galbraith (radial) plots for random effects models and (B) funnel plots for mixed-effect models. For mixed-effects models, study moderator is represented by volumetry technique (automated vs manual).
seizure counts/frequency and epilepsy duration), while only 3 studies assessed progression longitudinally (2 single-cohort, 1 multicohort study) (figure 4 10 we obtained an overall score of 1.5, indicative of low overall quality (table e-6). DISCUSSION We carried out a systematic review and meta-analysis of MRI morphometry studies addressing cumulative effects of atrophy in drugresistant TLE. Quantitative synthesis of study design variability revealed that an overwhelming majority of previous work was based on crosssectional inference, which related MRI markers to estimates of disease duration or seizure frequency. Meta-analytical modeling showed more marked atrophy in the ipsilateral hippocampus, with moderate effect sizes, in patients with longer epilepsy duration and more frequent seizures. Notably, several sensitivity analyses that excluded repeated studies from the same institution indicated virtually identical effects for ipsilateral hippocampal atrophy. While acrosstechnique heterogeneity and the inconsistent reporting styles precluded the application of meta-analytical modeling of progression beyond the hippocampus, a narrative synthesis emphasized the occurrence of changes often extending to extratemporal and subcortical regions. Cumulative thalamic damage represented a consistent finding, in line with evidence indicating a central role of thalamotemporal connections in the pathologic network of TLE. 55 The evaluated studies exhibited high heterogeneity with respect to inclusion criteria. First, patients were labelled as drug-resistant, uncontrolled, refractory, medically intractable, or chronic. The definition of drug-resistant epilepsy has posed considerable challenges, resulting in diverse formulations until unifying efforts of an International League Against Epilepsy task force in 2010. 56 Most studies (76.2%) included in our systematic assessment were conducted before 2010, and only 2 more recent reports classified patients according to these criteria. Variability in patient eligibility criteria increases heterogeneity. To adjust for this potential limitation, we assessed effects of epilepsy duration on ipsilateral hippocampal volumes in studies that included only patients evaluated for epilepsy surgery. Effects in this more restrictive assessment were virtually identical to those of the overall analysis. Second, studies differed with regards to the range of hippocampal anomalies in patients. Of note, the functional implications of progressive hippocampal damage may be equally important in patients presenting with already marked atrophy as in those with normal volumes. Correlations have in fact been documented between hippocampal volumes and preoperative memory scores, 57 and increasing evidence suggests that preoperative volumes may relate to postoperative memory performance. 58 It is crucial to emphasize that the predominating cross-sectional design confounds between-and within-subject effects and, thus, does not directly address progression. Moreover, it does not permit a direct control of aging-related effects, as chronological age and epilepsy duration are highly correlated. Cross-sectional investigations are also not adequately tailored to capture the effects of initial precipitating events, including prolonged febrile seizures or traumatic brain injury, on acute gray matter loss, its evolution over time, and their relationship with epilepsy severity. Conversely, longitudinal studies can directly assess within-subject trajectories, and dissociate pathologic change from aging if both patients and controls are included. The few longitudinal studies performed to date were sensitive in detecting cumulative atrophy across all lobes in patients. Moreover, these studies showed additional modulation of progression by seizure estimates in some regions, supporting a more detrimental disease course in patients with frequent seizures. 43, 44 Notably, no study has dissociated longitudinal effects in patients and controls. One study separately tracked change in both cohorts, 43 but did not directly test for progression, i.e., by statistically comparing longitudinal trajectories. A previous report, however, compared aging effects between patients and controls cross-sectionally, 41 and observed more marked effects in the former. These findings overall point to more severe age-related thinning in patients, with longitudinal assessments documenting effects of 0.02-0.05 mm/year, 41, 44 while reported rates of annual age-related change in healthy adults range between 0.001 and 0.008 mm. 59, 60 Widespread and potentially progressive atrophy may result from a complex combination of the effects of recurrent seizures and neuronal disconnection. 41 Moreover, several studies reported temporo-limbic morphometric abnormalities in asymptomatic relatives of patients with TLE, e1-e4 indicating that genetic factors may also contribute to atrophy. Due to our inclusion criteria, we could not compare drugresistant to well-controlled patients. Previous research has suggested potential effects of medication, including phenytoin and sodium valproate, on gray matter measurements.
e5-e6 Drug-related effects might thus be relevant to explain progressive structural damage in well-controlled patients.
e7-e8 On the other hand, recent evidence points to an association between longstanding TLE and tau pathology, a common sign of established neurodegenerative diseases, in the ipsilateral temporal lobe. e9 By potentially providing mechanistic insights into the cascade leading from repeated seizures to neuronal loss, the latter finding may offer a framework for conceptualizing progressive atrophy in uncontrolled TLE as a neurodegenerative process.
e10
In drug-resistant TLE, evidence exists in favor of the efficacy and superiority of surgical procedures compared to medical treatment.
1,2 Advantages of surgery are not limited to seizure control, but also encompass decreased mortality as well as improvements in psychosocial functioning and quality of life. Yet, epilepsy surgery is still underimplemented 4 and referrals for evaluation tend to occur several years after medication failure. 3 To provide evidence for disease progression beyond effects of aging and to identify underlying factors, longitudinal imaging studies are needed that follow both patient and control cohorts. Quantitative MRI contrasts, such as T1 and T2 relaxometry, may provide additional information on the effects of disease on microstructural integrity of the gray and white matter not captured by conventional weighted images. Arguably, longitudinal studies face logistic challenges, high costs, and risk of attrition. As the necessity for surgical treatment in drug-resistant cohorts may preclude tracking withinpatient change over considerable periods of time, structured and accelerated designs to systematically enroll patients at different time points in their disease course would be a feasible strategy. These studies may also help to discriminate patients with a benign disease course from those with aggressive progression, aiding patient stratification and contributing to the identification of disease biomarkers with validity at the individual level.
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